| Income Statement | 2024-12-31 | |||
|---|---|---|---|---|
| Revenues | 19,685 | |||
| Cost of revenues | 12,584 | |||
| Gross profit | 7,101 | |||
| Marketing and selling | 2,550 | |||
| Research and development | 749 | |||
| General and administrative | 5,695 | |||
| Total operating expenses | 8,994 | |||
| Operating loss | -1,893 | |||
| Other expense | -21 | |||
| Settlements | 2 | |||
| Total other expense | -23 | |||
| Net loss before provision for (benefit from) income taxes | -1,916 | |||
| Provision for (benefit from) income taxes | -55 | |||
| Net loss and comprehensive loss | -1,861 | |||
| Basic eps | -0.32 | |||
| Basic average shares | 5,867,000 | |||
| Diluted average shares | 5,867,000 | |||
PSYCHEMEDICS CORP (PMDI)
PSYCHEMEDICS CORP (PMDI)